Related Experiment Video
Updated: May 21, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Sedation for patients with movement disorders.
1Dental Department, Hainault Health Centre, Manford Way, Chigwell, Essex IG7 4DF, UK.
Dental sedation using nitrous oxide and midazolam effectively reduces movement disorders in patients with cerebral palsy. These sedation methods aid in managing involuntary movements during dental procedures in community settings.
Area of Science:
- Neurology
- Dentistry
- Pharmacology
Background:
- Movement disorders, such as those seen in cerebral palsy, can complicate dental treatment.
- Effective management of involuntary movements is crucial for successful dental care in these patients.
Observation:
- Two case reports detail the treatment of cerebral palsy patients in a community care setting.
- The study outlines general features of movement disorders and describes sedation techniques.
Findings:
- Inhalational sedation with nitrous oxide and oxygen, and intravenous sedation with midazolam were employed.
- Both inhalational sedation (IS) and intravenous sedation (IVS) proved beneficial in reducing unwanted movements during dental treatment.
Implications:
- Sedation offers a viable strategy for improving dental treatment outcomes for individuals with movement disorders.
- Community-based dental care settings can successfully implement these sedation techniques for enhanced patient management.
More Related Videos
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Stages of General Anesthesia
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...